These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15334177

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recombinant Activated Factor VII (Eptacog Alfa Activated, NovoSeven®) in Patients with Rare Congenital Bleeding Disorders. A Systematic Review on its Use in Surgical Procedures.
    Di Minno MND, Ambrosino P, Myasoedova V, Amato M, Ventre I, Tremoli E, Minno AD.
    Curr Pharm Des; 2017; 23(7):1125-1131. PubMed ID: 28034354
    [Abstract] [Full Text] [Related]

  • 5. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
    Di Minno G.
    Blood Rev; 2015 Jun; 29 Suppl 1():S26-33. PubMed ID: 26073366
    [Abstract] [Full Text] [Related]

  • 6. Recombinant activated factor VII in clinical practice: a 2014 update.
    Franchini M, Crestani S, Frattini F, Sissa C, Bonfanti C.
    J Thromb Thrombolysis; 2015 Feb; 39(2):235-40. PubMed ID: 25015059
    [Abstract] [Full Text] [Related]

  • 7. Recombinant activated factor VII in approved indications: Update on safety.
    Neufeld EJ, Négrier C, Benchikh El Fegoun S, Cooper DL, Rojas-Rios A, Seremetis S.
    Haemophilia; 2018 Jul; 24(4):e275-e277. PubMed ID: 30004625
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.
    Poon MC, d'Oiron R.
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S55-68. PubMed ID: 10850567
    [Abstract] [Full Text] [Related]

  • 10. The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework.
    Moltzan CJ, Anderson DA, Callum J, Fremes S, Hume H, Mazer CD, Poon MC, Rivard G, Rizoli S, Robinson S.
    Transfus Med; 2008 Apr; 18(2):112-20. PubMed ID: 18399845
    [Abstract] [Full Text] [Related]

  • 11. Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders.
    Birschmann I, Klamroth R, Eichler H, Schenk J, Kirchmaier CM, Halimeh S.
    Haemophilia; 2013 Sep; 19(5):679-85. PubMed ID: 23647644
    [Abstract] [Full Text] [Related]

  • 12. A comprehensive review of rFVIIa use in a tertiary care pediatric center.
    Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M.
    Pediatr Blood Cancer; 2008 May; 50(5):1013-7. PubMed ID: 17960639
    [Abstract] [Full Text] [Related]

  • 13. Recombinant activated factor VII as a universal haemostatic agent.
    Hedner U.
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
    [Abstract] [Full Text] [Related]

  • 14. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV, Mehta P, Waner M, Fink LM.
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.
    Siddiqui MA, Scott LJ.
    Drugs; 2005 Jan; 65(8):1161-77. PubMed ID: 15907148
    [Abstract] [Full Text] [Related]

  • 17. Recombinant activated factor VII (rFVIIa, NovoSeven).
    Agarwal MB, Patnaik M.
    J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
    [Abstract] [Full Text] [Related]

  • 18. Recombinant factor VIIa: a review on its clinical use.
    Franchini M.
    Int J Hematol; 2006 Feb; 83(2):126-38. PubMed ID: 16513530
    [Abstract] [Full Text] [Related]

  • 19. [Activated Factor VII - 31 years experience on clinical grounds].
    Udvardy M.
    Orv Hetil; 2017 Jun; 158(24):923-928. PubMed ID: 28604077
    [Abstract] [Full Text] [Related]

  • 20. Recombinant factor VIIa. An update on its clinical use.
    Franchini M, Zaffanello M, Veneri D.
    Thromb Haemost; 2005 Jun; 93(6):1027-35. PubMed ID: 15968384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.